Gasdermin D in Vitiligo After Narrow-band UVB
Part of Skin clinical trials.
This study looks at how narrow-band ultraviolet B (UVB) light therapy affects a protein called gasdermin D in people with vitiligo. It may help us understand why this treatment works for some people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had vitiligo that has not changed (stable) for at least 6 months.
- You are between 10 and 75 years old.
- You are not pregnant or breastfeeding.
- You have not had light therapy (phototherapy) before or recently.
- You are not taking other immune-suppressing medicines.
- You have stopped taking antioxidants or vitamins for 2 weeks before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment for people with active generalized vitiligo covering more than 5% of their body (not counting hands and feet). It also looks at a protein in the blood called s100B to see how it relates to the condition and treatment response.
This trial tests whether combining narrowband UVB light with topical steroids can help treat vitiligo, and looks at specific blood markers (CXCL11 and TEMRA) to see how the treatment affects the immune system. It may help patients with stable, non-segmental vitiligo who have not used systemic therapy in the last 3 months.
This trial tests whether combining hyperbaric oxygen therapy (breathing high-pressure oxygen in a chamber) with a specific type of ultraviolet light can help restore skin color in people with vitiligo. Vitiligo is a condition where patches of skin lose their pigment.
This study compares two treatments for vitiligo: narrowband UVB light therapy combined with either tacrolimus ointment or calcipotriol ointment. It aims to see which combination works better and is safer for people with stable, limited vitiligo.
This trial tests a new gel made from stem-cell substances (secretome) given with narrow-band UVB light therapy for stable non-segmental vitiligo. It compares two ways of applying the gel to see which works better.
This trial tests whether combining microneedling (tiny needle pricks to stimulate skin) with minoxidil cream, with or without special UV light therapy, can help restore skin color in people with stable vitiligo. It aims to find the most effective treatment combination for this skin condition.
Hear when a new Vitiligo, Generalized trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.